Navigation Links
Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious 'Outstanding Contribution' Award
Date:3/3/2011

WASHINGTON, March 3, 2011 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA), which represents the world's leading generic drug manufacturers and suppliers, has honored Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt with the industry's prestigious "Outstanding Contribution" Award.  

(Photo: http://photos.prnewswire.com/prnh/20110303/DC58687)

The award was presented at GPhA's Annual Meeting in Orlando, Florida.  PCMA represents the nation's PBMs which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.

"I'm honored to receive this award and proud to stand with GPhA, employers, and consumer groups in the fight for affordable prescription drugs," said PCMA President and CEO Mark Merritt.  

Proven PBM tools and techniques – including increasing the use of generic medications – has helped result in drug spending during the 2007-2009 period growing at its slowest annual rates in more than 40 years.   Research released by the Congressional Budget Office (CBO) found that the use of generic medications rather than brand-name medications in Medicare Part D saved beneficiaries and the program about $33 billion in 2007 with an additional $14 billion in savings expected as first-time generics enter the market through 2012. Over the past decade, generic medications have helped save the United States health care system $824 billion.  

The Generic Pharmaceutical Association (GPhA) represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 75 percent of the prescriptions dispensed in the U.S. but consume just 22 percent of the total drug spending.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Neurontin® Capsules
2. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
3. Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma
4. PCMA: Generics, Mail-Service Pharmacy Recognized as Ways to Reduce Costs for TRICARE Program
5. Reportlinker Adds Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013
6. Mylan Launches First Generic Version of Vfend® Tablets
7. PCMA: Some Drugmakers Lobbying to Limit E-Prescribing of Generics, Drug Safety Checks
8. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
9. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
10. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment
11. Mylans Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... 2016 According to a new ... 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by ... Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", published ... Market for the forecast period of 2016 to 2021. ... by 2021 from USD 117.3 Million in 2016, at ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama Information, ... billion in 2015.  Though these are challenging times ... opportunity for success for companies that remain optimistic ... of new growth prospects medical device companies spend ... and development (R&D) than do companies in other ...
(Date:5/25/2016)... , May 25, 2016 Digital ... issuance to it by the US Patent and ... company,s technology includes proprietary processes for electronic opt-­in ... health and wellness programs, HIPAA compliance and otherwise. ... "Our technology allows ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute ... for a sustainable product to aid in the rehabilitation process has steadily increased. Ekso ... of individuals with hemiplegia due to stroke. , Ekso Bionics has now received clearance ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought ... industry, from leading advocates, associations and industry leaders such as Bioness. , ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Beleza Medspa ... body fat composition regulations. This is the first time that Coolsculpting is being ... at least every six months to ensure they meet the prescribed body-fat standard, measured ...
(Date:5/27/2016)... ... ... Aimed at nurses and employees in the health care world, this installment ... nursing and health care industry. It also provides insight to the developing trends and ... As the nursing industry is coming out of one of the biggest recessions in ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... trusted name in the pharmaceutical, medical and food industries. Aside from its GMP ... certification (SIC), providing proof of successfully certified products, services and staff. , Validation ...
Breaking Medicine News(10 mins):